Split History
SNOA split history picture
Sonoma Pharmaceuticals (SNOA) has 1 split in our SNOA split history database. The split for SNOA took place on June 20, 2019. This was a 1 for 9 reverse split, meaning for each 9 shares of SNOA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 111.111111111111 share position following the split.

When a company such as Sonoma Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the SNOA split history from start to finish, an original position size of 1000 shares would have turned into 111.111111111111 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Sonoma Pharmaceuticals shares, starting with a $10,000 purchase of SNOA, presented on a split-history-adjusted basis factoring in the complete SNOA split history. SNOA split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/28/2014
End date: 05/23/2024
Start price/share: $31.77
End price/share: $0.19
Dividends collected/share: $0.00
Total return: -99.40%
Average Annual Total Return: -40.08%
Starting investment: $10,000.00
Ending investment: $59.83
Years: 9.99
Sonoma Pharmaceuticals is a global healthcare provider for developing and producing stabilized hypochlorous acid products for a range of applications, including wound care, animal health care, eye care, oral care and dermatological conditions. Co.'s products include: Celacyn® Scar Management Gel, which provides scar management by protecting and moisturizing wound and scar sites; Microcyn® Wound Care Management, which provides enhanced healing properties; Acuicyn™ Eyelid and Eyelash Hygiene, which provides eyelid and eyelash hygiene; and Microdacyn60® Oral Care, which supports the treatment of mouth and throat infections and the debridement and moistening of mouth lesions and thrush. According to our SNOA split history records, Sonoma Pharmaceuticals has had 1 split.
Date Ratio
06/20/20191 for 9
SNOA is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

SNPX Split History
SNSS Split History
SONN Split History
SPEX Split History
SQL Split History
SRDX Split History
SRGA Split History
SRPT Split History
SRRA Split History
SSH Split History

Also explore: SNOA shares outstanding history

Email EnvelopeFree SNOA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Tharimmune, Inc. (THAR)
BioCardia, Inc. (BCDA)
Lam Research Corporation (LRCX)
Akanda Corp. (AKAN)
Amphenol Corporation (APH)
Jaguar Health, Inc. (JAGX)
OpGen, Inc. (OPGN)
Blue Star Foods Corp. (BSFC)
Charles & Colvard, Ltd. (CTHR)
Seelos Therapeutics, Inc. (SEEL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

SNOA Insider Buying

SNOA Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.